Procept Biorobotics: Grows by 83% in Q1 and Raises Sales Forecast. The AQUABEAM System Could be Considered for Prostate Cancer Treatment!

Robotics stocks are one of the most important investment trends. Procept Biorobotics broke out to a 52-week high and is a leader stock. The 83% growth in the 1st quarter was convincing. The forecast was raised. An expansion into prostate cancer treatment is generating great imagination. Robotics is one of the most exciting investment trends. Procept Biorobotics (PRCT) currently stands out in this regard. After yesterday's figures and the updated outlook, the share moved to a 52-week high. With its AQUABEAM robotic system, the group...